Article
A potential anti-amyloidogenic therapy for type 2 diabetes based on the QBP1 peptide
2025-05-10
Abstract excerpt
The self-assembly and aggregation of human islet amyloid polypeptide (hIAPP, or amylin) into β-sheet-rich structures, such as oligomers and fibrils, are implicated in pancreatic β-cell dysfunction and failure, contributing to the pathogenesis of Type 2 Diabetes (T2D). Consequently, extensive research has focused on identifying inhibitors, particularly short peptides, capable of targeting hIAPP and disrupting its a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0140010c-c959-51bd-9078-c48ff2840ec8
- DOI
- 10.1101/2025.05.06.652241
